Home / Deferasirox / Canada
CA ATC V03AC03 · updated 2 Nov 2026
Deferasirox shortage in Canada
Is there a Deferasirox shortage in Canada?
Yes. As of 2 Nov 2026, 5 Deferasirox products are reported short in Canada, the first since 10 Mar 2026. The company estimate for the return is 12 Nov 2026. Main reason: manufacturing problem.
Also short in Italy, Spain, Ireland, Austria, Sweden, Japan, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | PMS-DEFERASIROX (TYPE J) (30) | PHARMASCIENCE INC | 10 Mar 2026 | 12 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JADENU (3 blister strips of 10) | NOVARTIS PHARMACEUTICALS CANADA INC | 24 Sep 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | EXJADE (4 blister strips of 7) anticipated | NOVARTIS PHARMACEUTICALS CANADA INC | 31 Dec 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | EXJADE (4 blister strips of 7) anticipated | NOVARTIS PHARMACEUTICALS CANADA INC | 28 Feb 2027 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JADENU (3 blister strips of 10) anticipated | NOVARTIS PHARMACEUTICALS CANADA INC | 30 Mar 2027 | not given | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.